Septic pelvic thrombophlebitis

Last updated

Septic pelvic thrombophlebitis (SPT), also known as suppurative pelvic thrombophlebitis, is a rare postpartum complication which consists of a persistent postpartum fever that is not responsive to broad-spectrum antibiotics, in which pelvic infection leads to infection of the vein wall and intimal damage leading to thrombogenesis in the ovarian veins (left or right, although right is more common due to dextroversion of the uterus). The thrombus is then invaded by microorganisms. Ascending infections cause 99% of postpartum SPT.

Contents

Septic pelvis thrombophlembitis is a cause of post-operative fever from untreated postpartum endometritis or parametritis. After 48 hours of unresolved postpartum endometritis (notably 48 hours of fever that is unaffected by antibiotics), SPT is assumed until proven otherwise (with pelvic radiography). Imaging studies can be helpful in patient refractory to broad-spectrum parenteral antibiotics to look for abscess, retained products, or septic pelvic thrombophlebitis. [1] Current treatments consist of a combination of antibiotics selected based on suspected pathogen(s), and anticoagulants.

Though the greatest risk factors involve delivery or delivery-related complications, in some rare cases, SPT may arise after abortion procedures [2] and in non-pregnant people with pelvic infections, pelvic surgeries, uterine fibroids, [3] or underlying cancer. [4]

SPT can also be further subcategorized into ovarian vein thrombosis (OVT) or puerperal ovarian vein thrombophlebitis (POVT) and deep septic pelvic thrombosis (DSPT). [5]

Pathogenesis

Septic pelvic thrombophlebitis (SPT) is an inflammatory process that, in conjunction with the physiological conditions of postpartum and proximity with potentially infected tissues (e.g. endometrium, chorion, amniotic fluid), leads to the formation of a clot blocking the ovarian vein. Injury of the ovarian vein endothelium during delivery or pelvic operations and bacterial invasion from nearby tissues triggers an inflammatory response within the vein wall. Bacteria, viruses and physical trauma can trigger prothrombic processes within the body through inflammation and tissue factor expression on endothelial cells and monocytes that activates the intrinsic coagulation pathway. [6]

In addition to the intravascular vessel wall damage, Virchow's triad of thrombogenesis is completed by the hypercoagulable state of pregnancy up to 6 weeks postpartum and blood stasis from both laying down in a hospital bed for an extended amount of time without walking and pregnancy-induced ovarian venous dilatation. [7] Deep vein thrombosis is generally a concern in operations involving the pelvis or lower extremities wherein during recovery, a person's ability to ambulate is limited after the operation. Blood stasis and thrombogenesis within the ovarian vein specifically is especially of concern after cesarean sections due to the combination of inevitable physical trauma to the intima of pelvic blood vessels, the three-fold increase in diameter if the ovarian veins, and that pooling of the blood in the pelvis as this is the lowest part of the person while laying in a hospital bed. Notably, most cases of SPT involve the right ovarian vein rather than the left ovarian vein due to its greater length, weaker valves, and left-to-right venous flow in the pelvic region while sitting in the upright position. [8]

Ovarian veins have close connections with the uterine and vaginal venous plexuses that are in proximity to tissues commonly host to pathogens, notably in cases of vaginosis or endometritis. Pathogens from these adjacent tissues infect the forming clot, and contributing to a positive feedback loop of inflammation. Bacterial organisms associated with SPT include anaerobic and aerobic streptococci, Proteus species, Bacteriodes species, staphylococci, E. coli, and Klebsiella. [9] Sepsis occurs after the pathogens infect and proliferate in the thrombus within the lumen, leading to persistent bacteremia.  Fatal complications include septic shock and septic pulmonary embolism, leading to acute respiratory distress syndrome.

Signs and symptoms

Septic pelvic thrombophlebitis (SPT) is often difficult to diagnose due to the absence of physical signs and symptoms. [10] SPT initially and most commonly presents as a fever anywhere from 5 to 21 days after delivery. [11] Temperatures of fever have been reported to be within 103 °F to 104 °F. [12]

The symptoms of SPT are similar to those of endometritis. Clinical signs include:

In rare cases, more serious postpartum complications may occur as a result of SPT such as pulmonary embolism. [13]

Risk Factors

Septic pelvic thrombophlembitis (SPT) occurs most often in bedridden patients after giving birth, or after having undergone a Caesarean section. The main risk factor of developing SPT is postpartum endometritis, which in turn is most commonly caused by a Caesarean section. The blood often pools in the pelvis as this is the lowest part of the patient while laying in a hospital bed. Other risk factors for developing endometritis, and subsequently SPT include:

Diagnosis

Septic pelvic thrombophlebitis (SPT) is mostly suspected when a spiking fever is not resolved using a broad spectrum antibiotic therapy. People often experience flank or abdominal pain which is non-colic and constant. The pain can vary in intensity and location. [10] Most often, SPT is diagnosed by the presence of fever, leucocytosis or positive blood cultures despite treating them with the standard antibiotic therapy. [6] Due to the nature of SPT, such as rare incidence and lack of specific clinical signs and symptoms, it is often misdiagnosed. [13]

SPT is very complex and difficult to see through scans because sometimes small blood clots cannot be detected by these machines. Due to the difficulty in suspecting thrombi in the ovarian veins, sometimes a presumptive diagnosis can be made in persons, especially in postpartum women. [18] This is the reason even healthy postpartum women are considered for anticoagulation therapy without no visualization of a thrombus in their scans. [18]

Imaging

The best way to surely diagnose SPT is by using a contrast-enhanced computed tomography (CT) scan. Imaging tools such as computed tomography (CT) and magnetic resonance imaging (MRI) are used to visually confirm presence of a thrombosed vessel. [10] CT and MRI show comparable results in diagnosing SPT but ultrasound has a lower detection ability. [19] Ultrasound can be helpful in some cases when there is already a confirmed thrombus present in addition to a positive blood culture result. It is not useful to evaluate a dural or pelvic vein thrombophlebitis because of its poor penetration abilities. [10]

Once the scan confirms the presence of a clot in addition to inflammation indicating thrombosis, it can be inferred looking at the blood cultures and symptoms that SPT is present. [20] Other laboratory tests like the complete blood count, blood chemistries, liver tests, enzyme tests, INR/ PT ratios for anticoagulation can also be done. [21] Ultrasonographic imaging can also support diagnosis of SPT. [13]

In the diagnosis of OVT, a characteristic sonographic finding will be an extended hypoechoic mass located anteriorly to the psoas. [22] Additionally, sonographic imaging will show a thrombosed and enlarged ovarian vein. [23]

Laboratory results

Septic pelvic thrombophlebitis will show laboratory results reflective of active inflammation such as elevated C-reactive protein (CRP) and white blood cell count (WBC). [5]

If available, both central and peripheral tip cultures should be sent for testing. [21] Depending on type and site of infection, gram stain and purulent culture can also be sent. [21]

Differential diagnosis

There are many other conditions that can mimic SPT, for example deep vein thrombosis (DVT) or other symptoms commonly experienced by cancer therapy patients. [24] Cancer therapy patients can also be experiencing bacterium positive results due to other agents which they cannot fight due to severe immuno-compromised abilities. [21]

Since septic pelvic thrombophlebitis is a diagnosis of exclusion, other causes of postpartum fever must be considered, such as infection of cesarean section wounds, episiotomy or laceration sites as well as endometritis, endomyometritis, mastitis, and physiologic breast engorgement. [1]

Treatment

Invasive procedures

Before pharmacological therapy was introduced, surgical procedures such as surgical excision of the thrombosed vein and venous ligation (tying off the vein in order to prevent blood from collecting in the vein) were the mainstays of treatment for septic pelvic thrombophlebitis. [10] [25] These procedures are now only reserved for severe cases of SPT when pharmacological therapy is not effective. [6]

The advancement of medical technology and diagnostic tools has allowed for non-invasive treatment for SPT, such as anticoagulant and antimicrobial therapy. [18]

Pharmacological therapy

Septic pelvic thrombophlebitis (SPT) is often associated with postpartum endometritis, so antibiotics are selected based on guidelines to treat endometritis. [26] [27] The first line treatment includes a combination of intravenous clindamycin and gentamicin. If enterococcus is suspected or isolated, ampicillin or vancomycin may be added to therapy. Clindamycin and gentamicin are not effective against enterococcus. Treated individuals typically respond to antibiotic treatment within 48 hours and fevers resolve within 96 hours. Intravenous administration of antibiotics are continued until the fever is resolved, pain improves, and the leukocyte count returns to baseline.

Clindamycin is an expensive antibiotic relative to other classes of antibiotics such as cephalosporins and penicillins. Therefore, there is concern about the availability of this drug in low-income settings. [26] There is a study that compared the use of penicillin plus gentamicin versus clindamycin plus gentamicin, which showed an increased rate of treatment failure of postpartum endometritis while on the penicillin and gentamicin combination. Although there is stronger evidence supporting the clinical efficacy of the clindamycin and gentamicin combination to treat postpartum endometritis, economic factors play a large role when selecting the best treatment regimen for a person.

The use of anticoagulation therapy is due to the underlying etiology of SPT which involves the promotion of the coagulation cascade. [28] A report revealed a rare case where a person developed a pulmonary embolism as a result of SPT and were successfully treated with warfarin. [13] However, in most or all cases, unfractionated heparin or low-molecular-weight heparin have been used. [10]

Heparin is commonly used in addition to antimicrobial therapy for the treatment of SPT. It is added to therapy if the person still has a persistent fever after five days despite being on antibiotics. [27] In a study which looked at forty-six postpartum persons with SPT who received heparin in addition to penicillin or chloramphenicol, over ninety percent responded with favorable outcomes such as reduced fever by no more than seven days. [29] The average length of heparin treatment which has been shown to induce an afebrile, or reduced fever, state is typically eight to nine days. [29] [30]

However, there is conflicting evidence which shows that the addition of heparin does not provide any added therapeutic benefit to antimicrobial therapy. A study involving fifteen persons who were diagnosed with SPT over a three year period compared clinical outcomes of persons with SPT who received only antimicrobial therapy versus the addition of heparin to antimicrobial therapy. The study concluded that there was no statistically significant difference in clinical outcomes, such as the length of fever and duration of their hospital stay. [24]

In people with persistent fevers after receiving antimicrobial therapy, a CT scan is recommended for further investigation. [18]

Epidemiology

Septic pelvic thrombophlebitis is a rare complication of pregnancy. A report states that a pregnant woman undergoing a cesarean section increases the risk of developing SPT . The incidence of SPT occurred in about 1 per 9000 vaginal deliveries and 1 per 800 cesarean sections. [24] The overall incidence of SPT was 1 per 3000 deliveries.

In a study that involved 44,922 deliveries, fifteen women were diagnosed with pelvic thrombophlebitis. However, no complications or deaths were reported. [10]

History

Septic pelvic thrombophlebitis was first described and diagnosed by von Recklinhausen at the end of the 19th century. [10] It was initially described as a pelvic infection where there was the presence of a thrombosis in one or both of the ovarian veins. This disease had a high incidence and mortality during this time period. Since this discovery occurred prior to the antibiotic era, von Recklinhausen proposed surgical excision as the preferred treatment. In 1951, Collins published and advocated the practice of ligature of the inferior vena and ovarian veins as the most effective treatment. It was reported that there was a 90 percent survival rate after the surgery. It was not until the late 1960s that combination antibiotic and heparin therapy became the preferred treatment plan for SPT. After pharmacological therapy became the preferred treatment for SPT, mortality rates drastically decreased. Furthermore, the advances in diagnostic tools (e.g. computed tomography and magnetic resonance imaging) and understanding of the disease contributed to improving treatment outcomes. Although the management of this disease has seen much improvement since its discovery at the end of the 19th century, there is still controversy in deciding what the most optimal treatment plan is. Antibiotic therapy is still the preferred treatment if SPT is expected, but adding on heparin is still up for debate because of conflicting evidence of whether or not it provides a therapeutic benefit.

Related Research Articles

<span class="mw-page-title-main">Bacterial vaginosis</span> Excessive growth of bacteria in the vagina

Bacterial vaginosis (BV) is an infection of the vagina caused by excessive growth of bacteria. Common symptoms include increased vaginal discharge that often smells like fish. The discharge is usually white or gray in color. Burning with urination may occur. Itching is uncommon. Occasionally, there may be no symptoms. Having BV approximately doubles the risk of infection by a number of sexually transmitted infections, including HIV/AIDS. It also increases the risk of early delivery among pregnant women.

<span class="mw-page-title-main">Pelvic inflammatory disease</span> Infection of uterus, fallopian tubes, ovaries or the inner surface of pelvis

Pelvic inflammatory disease, also known as pelvic inflammatory disorder (PID), is an infection of the upper part of the female reproductive system, namely the uterus, fallopian tubes, and ovaries, and inside of the pelvis. Often, there may be no symptoms. Signs and symptoms, when present, may include lower abdominal pain, vaginal discharge, fever, burning with urination, pain with sex, bleeding after sex, or irregular menstruation. Untreated PID can result in long-term complications including infertility, ectopic pregnancy, chronic pelvic pain, and cancer.

<span class="mw-page-title-main">Lemierre's syndrome</span> Medical condition

Lemierre's syndrome is infectious thrombophlebitis of the internal jugular vein. It most often develops as a complication of a bacterial sore throat infection in young, otherwise healthy adults. The thrombophlebitis is a serious condition and may lead to further systemic complications such as bacteria in the blood or septic emboli.

<span class="mw-page-title-main">Venous thrombosis</span> Blood clot (thrombus) that forms within a vein

Venous thrombosis is blockage of a vein caused by a thrombus. A common form of venous thrombosis is deep vein thrombosis (DVT), when a blood clot forms in the deep veins. If a thrombus breaks off (embolizes) and flows to the lungs to lodge there, it becomes a pulmonary embolism (PE), a blood clot in the lungs. The conditions of DVT only, DVT with PE, and PE only, are all captured by the term venous thromboembolism (VTE).

Phlebitis is inflammation of a vein, usually in the legs. It most commonly occurs in superficial veins. Phlebitis often occurs in conjunction with thrombosis and is then called thrombophlebitis or superficial thrombophlebitis. Unlike deep vein thrombosis, the probability that superficial thrombophlebitis will cause a clot to break up and be transported in pieces to the lung is very low.

<span class="mw-page-title-main">Postpartum infections</span> Human disease

Postpartum infections, also known as childbed fever and puerperal fever, are any bacterial infections of the female reproductive tract following childbirth or miscarriage. Signs and symptoms usually include a fever greater than 38.0 °C (100.4 °F), chills, lower abdominal pain, and possibly bad-smelling vaginal discharge. It usually occurs after the first 24 hours and within the first ten days following delivery.

Recurrent miscarriage or recurrent pregnancy loss is three or more consecutive pregnancy losses. In contrast, infertility is the inability to conceive. In many cases the cause of RPL is unknown. After three or more losses, a thorough evaluation is recommended by American Society of Reproductive Medicine. While accurate figures are not available, it has been estimated that anywhere between 1% and 5% of couples trying to have children are affected by recurrent miscarriage.

<span class="mw-page-title-main">Complications of pregnancy</span> Medical condition

Complications of pregnancy are health problems that are related to, or arise during pregnancy. Complications that occur primarily during childbirth are termed obstetric labor complications, and problems that occur primarily after childbirth are termed puerperal disorders. While some complications improve or are fully resolved after pregnancy, some may lead to lasting effects, morbidity, or in the most severe cases, maternal or fetal mortality.

<span class="mw-page-title-main">Endometritis</span> Medical condition

Endometritis is inflammation of the inner lining of the uterus (endometrium). Symptoms may include fever, lower abdominal pain, and abnormal vaginal bleeding or discharge. It is the most common cause of infection after childbirth. It is also part of spectrum of diseases that make up pelvic inflammatory disease.

<span class="mw-page-title-main">Chorioamnionitis</span> Medical condition

Chorioamnionitis, also known as intra-amniotic infection (IAI), is inflammation of the fetal membranes, usually due to bacterial infection. In 2015, a National Institute of Child Health and Human Development Workshop expert panel recommended use of the term "triple I" to address the heterogeneity of this disorder. The term triple I refers to intrauterine infection or inflammation or both and is defined by strict diagnostic criteria, but this terminology has not been commonly adopted although the criteria are used.

<span class="mw-page-title-main">Cavernous sinus thrombosis</span> Medical condition

Cavernous sinus thrombosis (CST) is the formation of a blood clot within the cavernous sinus, a cavity at the base of the brain which drains deoxygenated blood from the brain back to the heart. This is a rare disorder and can be of two types–septic cavernous thrombosis and aseptic cavernous thrombosis. The most common form is septic cavernous sinus thrombosis. The cause is usually from a spreading infection in the nose, sinuses, ears, or teeth. Staphylococcus aureus and Streptococcus are often the associated bacteria.

<span class="mw-page-title-main">Ovarian vein</span>

The ovarian vein, the female gonadal vein, carries deoxygenated blood from its corresponding ovary to inferior vena cava or one of its tributaries. It is the female equivalent of the testicular vein, and is the venous counterpart of the ovarian artery. It can be found in the suspensory ligament of the ovary.

Hypercoagulability in pregnancy is the propensity of pregnant women to develop thrombosis. Pregnancy itself is a factor of hypercoagulability, as a physiologically adaptive mechanism to prevent post partum bleeding. However, when combined with an additional underlying hypercoagulable states, the risk of thrombosis or embolism may become substantial.

<span class="mw-page-title-main">Superficial thrombophlebitis</span> Medical condition

Superficial thrombophlebitis is a thrombosis and inflammation of superficial veins which presents as a painful induration with erythema, often in a linear or branching configuration forming cords.

Septic thrombophlebitis refers to venous thrombosis and inflammation associated with bacteremia.

Septic abortion describes any type of abortion, due to an upper genital tract bacterial infection including the inflammation of the endometrium during or after 20 weeks of gestation. The genital tract during this period is particularly vulnerable to infection, and sepsis in most cases is caused by a combination of factors both due to facility conditions and/or individual predispositions. The infection often starts in the placenta and fetus, with a potential complication of also affecting the uterus, that can result in sepsis spreading to surrounding organs, or pelvic infections.

<span class="mw-page-title-main">Superficial vein thrombosis</span> Medical condition

Superficial vein thrombosis (SVT) is a blood clot formed in a superficial vein, a vein near the surface of the body. Usually there is thrombophlebitis, which is an inflammatory reaction around a thrombosed vein, presenting as a painful induration with redness. SVT itself has limited significance when compared to a deep vein thrombosis (DVT), which occurs deeper in the body at the deep venous system level. However, SVT can lead to serious complications, and is therefore no longer regarded as a benign condition. If the blood clot is too near the saphenofemoral junction there is a higher risk of pulmonary embolism, a potentially life-threatening complication.

<span class="mw-page-title-main">Tubal factor infertility</span> Medical condition

Tubal factor infertility (TFI) is female infertility caused by diseases, obstructions, damage, scarring, congenital malformations or other factors which impede the descent of a fertilized or unfertilized ovum into the uterus through the Fallopian tubes and prevents a normal pregnancy and full term birth. Tubal factors cause 25-30% of infertility cases. Tubal factor is one complication of Chlamydia trachomatis infection in women.

<span class="mw-page-title-main">Tubo-ovarian abscess</span> One of the late complications of pelvic inflammatory disease

A tubo-ovarian abscess (TOA) is one of the late complications of pelvic inflammatory disease (PID) and can be life-threatening if the abscess ruptures and results in sepsis. It consists of an encapsulated or confined pocket of pus with defined boundaries that forms during an infection of a fallopian tube and ovary. These abscesses are found most commonly in reproductive age women and typically result from upper genital tract infection. It is an inflammatory mass involving the fallopian tube, ovary and, occasionally, other adjacent pelvic organs. A TOA can also develop as a complication of a hysterectomy.

The exact role of Mycoplasma hominis in regards to a number of conditions related to pregnant women and their (unborn) offspring is controversial. This is mainly because many healthy adults have genitourinary colonization with Mycoplasma, published studies on pathogenicity have important design limitations and the organisms are very difficult to detect. The likelihood of colonization with M. hominis appears directly linked to the number of lifetime sexual partners Neonatal colonization does occur, but only through normal vaginal delivery. Caesarean section appears protective against colonization and is much less common. Neonatal colonization is transient.

References

  1. 1 2 Callaghan T (2013). Blueprints Obstetrics and Gynecology. Baltimore: Lippincott Williams & Wilkins. ISBN   978-1-4511-1702-8.
  2. Simons GR, Piwnica-Worms DR, Goldhaber SZ (September 1993). "Ovarian vein thrombosis". American Heart Journal. 126 (3 Pt 1): 641–7. doi:10.1016/0002-8703(93)90415-6. PMID   8362720.
  3. Haynes MC, Lu BY, Winkel AF (February 2014). "Ovarian vein thrombophlebitis related to large uterine myoma". Obstetrics and Gynecology. 123 (2 Pt 2 Suppl 2): 450–453. doi:10.1097/AOG.0000000000000091. PMID   24413242. S2CID   22206335.
  4. Jacoby WT, Cohan RH, Baker ME, Leder RA, Nadel SN, Dunnick NR (August 1990). "Ovarian vein thrombosis in oncology patients: CT detection and clinical significance". AJR. American Journal of Roentgenology. 155 (2): 291–4. doi:10.2214/ajr.155.2.2115254. PMID   2115254.
  5. 1 2 da Silva Cunha M, Godinho AB, Botelho R, de Almeida JP (January 2018). "Postpartum septic pelvic thrombophlebitis after caesarean delivery: a case report". Case Reports in Women's Health. 17: 5–7. doi:10.1016/j.crwh.2018.02.004. PMC   5869062 . PMID   29594006.
  6. 1 2 3 Valerio L, Riva N (August 2020). "Head, Neck, and Abdominopelvic Septic Thrombophlebitis: Current Evidence and Challenges in Diagnosis and Treatment". Hamostaseologie. 40 (3): 301–310. doi: 10.1055/a-1177-5127 . PMID   32726825.
  7. Hodgkinson CP (January 1953). "Physiology of the ovarian veins during pregnancy". Obstetrics and Gynecology. 1 (1): 26–37. PMID   13013637.
  8. Roepke RM, de Campos FP, Lovisolo SM, Santos EH (2014). "Septic pelvic thrombophlebitis of unknown origin: an ever threatening entity". Autopsy & Case Reports. 4 (3): 39–46. doi:10.4322/acr.2014.027. PMC   5444397 . PMID   28573117.
  9. Dunnihoo DR, Gallaspy JW, Wise RB, Otterson WN (July 1991). "Postpartum ovarian vein thrombophlebitis: a review". Obstetrical & Gynecological Survey. 46 (7): 415–27. doi:10.1097/00006254-199107000-00002. PMID   1876354.
  10. 1 2 3 4 5 6 7 8 9 Garcia J, Aboujaoude R, Apuzzio J, Alvarez JR (2006). "Septic pelvic thrombophlebitis: diagnosis and management". Infectious Diseases in Obstetrics and Gynecology. 2006: 15614. doi: 10.1155/IDOG/2006/15614 . PMC   1581461 . PMID   17485796.
  11. Nezhat C, Farhady P, Lemyre M (2009). "Septic pelvic thrombophlebitis following laparoscopic hysterectomy". JSLS. 13 (1): 84–6. PMC   3015896 . PMID   19366549.
  12. Dunn LJ, Van Voorhis LW (February 1967). "Enigmatic fever and pelvic thrombophlebitis. Response to anticoagulants". The New England Journal of Medicine. 276 (5): 265–8. doi:10.1056/NEJM196702022760505. PMID   6016063.
  13. 1 2 3 4 5 Fei Z, Peng A, Wang L, Zhang L (June 2020). "Pulmonary embolism caused by postpartum ovarian vein thrombophlebitis after vaginal delivery: Case report and brief review of the literature". Journal of Clinical Ultrasound. 48 (5): 291–293. doi:10.1002/jcu.22814. PMID   31930727. S2CID   210193539.
  14. Dotters-Katz SK, Smid MC, Grace MR, Thompson JL, Heine RP, Manuck T (September 2017). "Risk Factors for Postpartum Septic Pelvic Thrombophlebitis: A Multicenter Cohort". American Journal of Perinatology. 34 (11): 1148–1151. doi:10.1055/s-0037-1604245. PMID   28704844. S2CID   5949343.
  15. Isler CM, Rinehart BK, Terrone DA, Crews JH, Magann EF, Martin JN (2004). "Septic pelvic thrombophlebitis and preeclampsia are related disorders". Hypertension in Pregnancy. 23 (1): 121–7. doi:10.1081/PRG-120029858. PMID   15117606. S2CID   26122520.
  16. Revzin MV, Mathur M, Dave HB, Macer ML, Spektor M (September 2016). "Pelvic Inflammatory Disease: Multimodality Imaging Approach with Clinical-Pathologic Correlation". Radiographics. 36 (5): 1579–96. doi:10.1148/rg.2016150202. PMID   27618331.
  17. Yamamoto S, Okamoto K, Okugawa S, Moriya K (April 2019). "Fusobacterium necrophorum septic pelvic thrombophlebitis after intrauterine device insertion". International Journal of Gynaecology and Obstetrics. 145 (1): 122–123. doi:10.1002/ijgo.12760. PMID   30648745. S2CID   58613407.
  18. 1 2 3 4 Witlin AG, Sibai BM (May 1995). "Postpartum ovarian vein thrombosis after vaginal delivery: a report of 11 cases". Obstetrics and Gynecology. 85 (5 Pt 1): 775–80. doi:10.1016/0029-7844(95)00040-X. PMID   7724112. S2CID   33380496.
  19. Uzquiano NG, Beall DP (2008). "Septic pelvic thrombophlebitis". AppliedRadiology.
  20. Losno RA, Vidal-Sicart S, Grau JM (June 2019). "Multiple pyomyositis secondary to septic thrombophlebitis". Medicina Clinica. 152 (12): 515–516. doi:10.1016/j.medcli.2018.07.020. PMID   30340839.
  21. 1 2 3 4 Lipe DN, Foris LA, King KC (2017). "Septic Thrombophlebitis". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID   28613482 . Retrieved 2021-07-27.
  22. Johnson SC, Esclapes M (1998). "Sonography of postpartum ovarian vein thrombophlebitis". Journal of Clinical Ultrasound. 26 (3): 143–9. doi:10.1002/(SICI)1097-0096(199803/04)26:3<143::AID-JCU6>3.0.CO;2-M. PMID   9502037.
  23. Hadas-Halpern I, Patlas M, Fisher D (2002). "Postpartum ovarian vein thrombophlebitis: sonographic diagnosis". Abdominal Imaging. 27 (1): 93–5. doi:10.1007/s00261-001-0034-7. PMID   11740617. S2CID   35701609.
  24. 1 2 3 Brown CE, Stettler RW, Twickler D, Cunningham FG (July 1999). "Puerperal septic pelvic thrombophlebitis: incidence and response to heparin therapy". American Journal of Obstetrics and Gynecology. 181 (1): 143–8. doi:10.1016/s0002-9378(99)70450-3. PMID   10411810.
  25. "Varicose vein stripping: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 2021-08-03.
  26. 1 2 "WHO recommendations for prevention and treatment of maternal peripartum infections" (PDF). World Health Organization. 2015.
  27. 1 2 Dalton E, Castillo E (September 2014). "Post partum infections: A review for the non-OBGYN". Obstetric Medicine. 7 (3): 98–102. doi:10.1177/1753495X14522784. PMC   4934978 . PMID   27512432.
  28. Malkamy H (1980). "Heparin therapy in postcesarean septic pelvic thrombophlebitis". International Journal of Gynaecology and Obstetrics. 17 (6): 564–6. doi:10.1002/j.1879-3479.1980.tb00208.x. PMID   6106573. S2CID   1452616.
  29. 1 2 Josey WE, Staggers SR (September 1974). "Heparin therapy in septic pelvic thrombophlebitis: a study of 46 cases". American Journal of Obstetrics and Gynecology. 120 (2): 228–33. doi:10.1016/0002-9378(74)90369-X. PMID   4413660.
  30. Witlin AG, Mercer BM, Sibai BM (1996). "Septic pelvic thrombophlebitis or refractory postpartum fever of undetermined etiology". The Journal of Maternal-Fetal Medicine. 5 (6): 355–8. doi:10.1002/(SICI)1520-6661(199611/12)5:6<355::AID-MFM12>3.0.CO;2-G. PMID   8972414.